s-propylcysteine has been researched along with Alzheimer Disease in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ho, MW; Lin, CY; Mong, MC; Tsai, SJ; Yin, MC | 1 |
Chiu, CP; Tsai, SJ; Yang, HT; Yin, MC | 1 |
2 other study(ies) available for s-propylcysteine and Alzheimer Disease
Article | Year |
---|---|
s-Ethyl cysteine and s-propyl cysteine alleviate beta-amyloid induced cytotoxicity in nerve growth factor differentiated PC12 cells.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Cell Differentiation; Cell Survival; Cysteine; DNA Fragmentation; Humans; Membrane Potential, Mitochondrial; Nerve Growth Factor; Neurons; Neuroprotective Agents; PC12 Cells; Rats | 2010 |
s-Allyl cysteine, s-ethyl cysteine, and s-propyl cysteine alleviate β-amyloid, glycative, and oxidative injury in brain of mice treated by D-galactose.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Brain; Cysteine; Disease Models, Animal; Galactose; Glycosylation; Humans; Male; Mice; Mice, Inbred C57BL; Oxidative Stress | 2011 |